Regulatory News

Filters

Date / Time Source Ticker Company Sector Market Cap Announcement
26 Mar 2019 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Cancellation of AIM Listing
15 Mar 2019 14:35 RNS RLM:LON Realm Therapeutics Health £57.1m Result of General Meeting
18 Feb 2019 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Update on Strategic Review Re-release
15 Feb 2019 18:20 RNS RLM:LON Realm Therapeutics Health £57.1m Update on Strategic Review
29 Nov 2018 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Update on Strategic Review
01 Oct 2018 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Provides Update on Timing of Formal Sale Process
17 Sep 2018 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Corporate Update and Hiring of Advisor
14 Aug 2018 07:10 RNS RLM:LON Realm Therapeutics Health £57.1m Half-year Report
07 Aug 2018 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Notice of Results
04 Jul 2018 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m SEC registration effective NASDAQ listing approved
14 Jun 2018 10:54 RNS RLM:LON Realm Therapeutics Health £57.1m Result of AGM
24 May 2018 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Enrollment complete for Phase 2 study of PR022
23 May 2018 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Filing with US SEC to Facilitate Nasdaq Listing
21 May 2018 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Data Presentation at IID 2018
02 May 2018 12:39 RNS RLM:LON Realm Therapeutics Health £57.1m Annual Financial Report Available
02 May 2018 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Final Results
02 May 2018 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Realm Files Registration for Nasdaq Listing of ADS
26 Apr 2018 14:32 RNS RLM:LON Realm Therapeutics Health £57.1m Notice of Results
12 Mar 2018 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Clinical Update including PR013 Phase II results
15 Feb 2018 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Clinical and Business Update
15 Dec 2017 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Director/PDMR Shareholding
12 Dec 2017 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m First Patient Dosed in Phase 2 Study of PR013
05 Dec 2017 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m First Patient Dosed in Phase 2 Study of PR022
17 Nov 2017 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Directorate Change
12 Oct 2017 15:07 RNS RLM:LON Realm Therapeutics Health £57.1m Realm Therapeutics: Completion of £19.3m Placing
09 Oct 2017 11:35 RNS RLM:LON Realm Therapeutics Health £57.1m Result of General Meeting
22 Sep 2017 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Interim Results
22 Sep 2017 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Proposed Placing to raise £19.3 million
21 Sep 2017 18:01 RNS RLM:LON Realm Therapeutics Health £57.1m Proposed Placing to raise £19.3 million
21 Sep 2017 18:00 RNS RLM:LON Realm Therapeutics Health £57.1m Interim Results
11 Sep 2017 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m FDA Permits PR013 to Proceed to Phase II Trial
02 Aug 2017 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Submission of Investigational New Drug Application
06 Jun 2017 11:05 RNS RLM:LON Realm Therapeutics Health £57.1m Result of AGM
11 May 2017 12:21 RNS RLM:LON Realm Therapeutics Health £57.1m Notice of AGM
23 Mar 2017 14:57 RNS RLM:LON Realm Therapeutics Health £57.1m Annual Report and Accounts Available
23 Mar 2017 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Final Results and Business Update
28 Feb 2017 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m FDA permits PR022 to Proceed to Phase 2 Trial
30 Jan 2017 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Research Update - Submission of first IND
04 Jan 2017 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Grant of Options
21 Dec 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m PDMR dealing
16 Dec 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Ivan Gergel appointed as Non-Executive Director
07 Dec 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Change of name to Realm Therapeutics
18 Nov 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Grant of Options
16 Nov 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Development Programmes Update & Company Renaming
10 Oct 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Completion of Supermarket Retail Business Disposal
07 Oct 2016 17:52 RNS RLM:LON Realm Therapeutics Health £57.1m Completion of Supermarket Retail Business Disposal
06 Oct 2016 11:43 RNS RLM:LON Realm Therapeutics Health £57.1m Result of General Meeting
23 Sep 2016 14:47 RNS RLM:LON Realm Therapeutics Health £57.1m Director/PDMR Dealing
22 Sep 2016 14:15 RNS RLM:LON Realm Therapeutics Health £57.1m Grant of Options
20 Sep 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Half-year Report
20 Sep 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Proposed Disposal of Supermarket Retail Business
17 Aug 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m PuriCore Receives Two U.S. Patents
16 Jun 2016 11:39 RNS RLM:LON Realm Therapeutics Health £57.1m Result of AGM
09 Jun 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Completion of Pre-IND Meeting with FDA on PR022
27 May 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Resolution reached with EPA
14 Apr 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Appointment of Dr. Christian Peters as CMO
31 Mar 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Notice of AGM
29 Mar 2016 15:11 RNS RLM:LON Realm Therapeutics Health £57.1m Director Dealing
29 Mar 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Grant of Options
24 Mar 2016 15:22 RNS RLM:LON Realm Therapeutics Health £57.1m Annual Financial Report
24 Mar 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Final Results
01 Mar 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Appointment of Dr Simba Gill to the Board
19 Feb 2016 09:30 RNS RLM:LON Realm Therapeutics Health £57.1m Blocklisting Interim Review
08 Feb 2016 07:00 RNS RLM:LON Realm Therapeutics Health £57.1m Strategic Review and Trading Update
14 Oct 2015 17:13 RNS RLM:LON Realm Therapeutics Health £57.1m Director Dealing
Date / Time Source Company % Chg
26 Mar 2019 07:00 RNS Realm Therapeutics 0.30%
Cancellation of AIM Listing
15 Mar 2019 14:35 RNS Realm Therapeutics 0.30%
Result of General Meeting
18 Feb 2019 07:00 RNS Realm Therapeutics 0.30%
Update on Strategic Review Re-release
15 Feb 2019 18:20 RNS Realm Therapeutics 0.30%
Update on Strategic Review
29 Nov 2018 07:00 RNS Realm Therapeutics 0.30%
Update on Strategic Review
01 Oct 2018 07:00 RNS Realm Therapeutics 0.30%
Provides Update on Timing of Formal Sale Process
17 Sep 2018 07:00 RNS Realm Therapeutics 0.30%
Corporate Update and Hiring of Advisor
14 Aug 2018 07:10 RNS Realm Therapeutics 0.30%
Half-year Report
07 Aug 2018 07:00 RNS Realm Therapeutics 0.30%
Notice of Results
04 Jul 2018 07:00 RNS Realm Therapeutics 0.30%
SEC registration effective NASDAQ listing approved
14 Jun 2018 10:54 RNS Realm Therapeutics 0.30%
Result of AGM
24 May 2018 07:00 RNS Realm Therapeutics 0.30%
Enrollment complete for Phase 2 study of PR022
23 May 2018 07:00 RNS Realm Therapeutics 0.30%
Filing with US SEC to Facilitate Nasdaq Listing
21 May 2018 07:00 RNS Realm Therapeutics 0.30%
Data Presentation at IID 2018
02 May 2018 12:39 RNS Realm Therapeutics 0.30%
Annual Financial Report Available
02 May 2018 07:00 RNS Realm Therapeutics 0.30%
Final Results
02 May 2018 07:00 RNS Realm Therapeutics 0.30%
Realm Files Registration for Nasdaq Listing of ADS
26 Apr 2018 14:32 RNS Realm Therapeutics 0.30%
Notice of Results
12 Mar 2018 07:00 RNS Realm Therapeutics 0.30%
Clinical Update including PR013 Phase II results
15 Feb 2018 07:00 RNS Realm Therapeutics 0.30%
Clinical and Business Update
15 Dec 2017 07:00 RNS Realm Therapeutics 0.30%
Director/PDMR Shareholding
12 Dec 2017 07:00 RNS Realm Therapeutics 0.30%
First Patient Dosed in Phase 2 Study of PR013
05 Dec 2017 07:00 RNS Realm Therapeutics 0.30%
First Patient Dosed in Phase 2 Study of PR022
17 Nov 2017 07:00 RNS Realm Therapeutics 0.30%
Directorate Change
12 Oct 2017 15:07 RNS Realm Therapeutics 0.30%
Realm Therapeutics: Completion of £19.3m Placing
09 Oct 2017 11:35 RNS Realm Therapeutics 0.30%
Result of General Meeting
22 Sep 2017 07:00 RNS Realm Therapeutics 0.30%
Interim Results
22 Sep 2017 07:00 RNS Realm Therapeutics 0.30%
Proposed Placing to raise £19.3 million
21 Sep 2017 18:01 RNS Realm Therapeutics 0.30%
Proposed Placing to raise £19.3 million
21 Sep 2017 18:00 RNS Realm Therapeutics 0.30%
Interim Results
11 Sep 2017 07:00 RNS Realm Therapeutics 0.30%
FDA Permits PR013 to Proceed to Phase II Trial
02 Aug 2017 07:00 RNS Realm Therapeutics 0.30%
Submission of Investigational New Drug Application
06 Jun 2017 11:05 RNS Realm Therapeutics 0.30%
Result of AGM
11 May 2017 12:21 RNS Realm Therapeutics 0.30%
Notice of AGM
23 Mar 2017 14:57 RNS Realm Therapeutics 0.30%
Annual Report and Accounts Available
23 Mar 2017 07:00 RNS Realm Therapeutics 0.30%
Final Results and Business Update
28 Feb 2017 07:00 RNS Realm Therapeutics 0.30%
FDA permits PR022 to Proceed to Phase 2 Trial
30 Jan 2017 07:00 RNS Realm Therapeutics 0.30%
Research Update - Submission of first IND
04 Jan 2017 07:00 RNS Realm Therapeutics 0.30%
Grant of Options
21 Dec 2016 07:00 RNS Realm Therapeutics 0.30%
PDMR dealing
16 Dec 2016 07:00 RNS Realm Therapeutics 0.30%
Ivan Gergel appointed as Non-Executive Director
07 Dec 2016 07:00 RNS Realm Therapeutics 0.30%
Change of name to Realm Therapeutics
18 Nov 2016 07:00 RNS Realm Therapeutics 0.30%
Grant of Options
16 Nov 2016 07:00 RNS Realm Therapeutics 0.30%
Development Programmes Update & Company Renaming
10 Oct 2016 07:00 RNS Realm Therapeutics 0.30%
Completion of Supermarket Retail Business Disposal
07 Oct 2016 17:52 RNS Realm Therapeutics 0.30%
Completion of Supermarket Retail Business Disposal
06 Oct 2016 11:43 RNS Realm Therapeutics 0.30%
Result of General Meeting
23 Sep 2016 14:47 RNS Realm Therapeutics 0.30%
Director/PDMR Dealing
22 Sep 2016 14:15 RNS Realm Therapeutics 0.30%
Grant of Options
20 Sep 2016 07:00 RNS Realm Therapeutics 0.30%
Half-year Report
20 Sep 2016 07:00 RNS Realm Therapeutics 0.30%
Proposed Disposal of Supermarket Retail Business
17 Aug 2016 07:00 RNS Realm Therapeutics 0.30%
PuriCore Receives Two U.S. Patents
16 Jun 2016 11:39 RNS Realm Therapeutics 0.30%
Result of AGM
09 Jun 2016 07:00 RNS Realm Therapeutics 0.30%
Completion of Pre-IND Meeting with FDA on PR022
27 May 2016 07:00 RNS Realm Therapeutics 0.30%
Resolution reached with EPA
14 Apr 2016 07:00 RNS Realm Therapeutics 0.30%
Appointment of Dr. Christian Peters as CMO
31 Mar 2016 07:00 RNS Realm Therapeutics 0.30%
Notice of AGM
29 Mar 2016 15:11 RNS Realm Therapeutics 0.30%
Director Dealing
29 Mar 2016 07:00 RNS Realm Therapeutics 0.30%
Grant of Options
24 Mar 2016 15:22 RNS Realm Therapeutics 0.30%
Annual Financial Report
24 Mar 2016 07:00 RNS Realm Therapeutics 0.30%
Final Results
01 Mar 2016 07:00 RNS Realm Therapeutics 0.30%
Appointment of Dr Simba Gill to the Board
19 Feb 2016 09:30 RNS Realm Therapeutics 0.30%
Blocklisting Interim Review
08 Feb 2016 07:00 RNS Realm Therapeutics 0.30%
Strategic Review and Trading Update
14 Oct 2015 17:13 RNS Realm Therapeutics 0.30%
Director Dealing
Date / Time Company % Chg
26 Mar 2019 07:00 Realm Therapeutics 0.30%
Cancellation of AIM Listing
15 Mar 2019 14:35 Realm Therapeutics 0.30%
Result of General Meeting
18 Feb 2019 07:00 Realm Therapeutics 0.30%
Update on Strategic Review Re-release
15 Feb 2019 18:20 Realm Therapeutics 0.30%
Update on Strategic Review
29 Nov 2018 07:00 Realm Therapeutics 0.30%
Update on Strategic Review
01 Oct 2018 07:00 Realm Therapeutics 0.30%
Provides Update on Timing of Formal Sale Process
17 Sep 2018 07:00 Realm Therapeutics 0.30%
Corporate Update and Hiring of Advisor
14 Aug 2018 07:10 Realm Therapeutics 0.30%
Half-year Report
07 Aug 2018 07:00 Realm Therapeutics 0.30%
Notice of Results
04 Jul 2018 07:00 Realm Therapeutics 0.30%
SEC registration effective NASDAQ listing approved
14 Jun 2018 10:54 Realm Therapeutics 0.30%
Result of AGM
24 May 2018 07:00 Realm Therapeutics 0.30%
Enrollment complete for Phase 2 study of PR022
23 May 2018 07:00 Realm Therapeutics 0.30%
Filing with US SEC to Facilitate Nasdaq Listing
21 May 2018 07:00 Realm Therapeutics 0.30%
Data Presentation at IID 2018
02 May 2018 12:39 Realm Therapeutics 0.30%
Annual Financial Report Available
02 May 2018 07:00 Realm Therapeutics 0.30%
Final Results
02 May 2018 07:00 Realm Therapeutics 0.30%
Realm Files Registration for Nasdaq Listing of ADS
26 Apr 2018 14:32 Realm Therapeutics 0.30%
Notice of Results
12 Mar 2018 07:00 Realm Therapeutics 0.30%
Clinical Update including PR013 Phase II results
15 Feb 2018 07:00 Realm Therapeutics 0.30%
Clinical and Business Update
15 Dec 2017 07:00 Realm Therapeutics 0.30%
Director/PDMR Shareholding
12 Dec 2017 07:00 Realm Therapeutics 0.30%
First Patient Dosed in Phase 2 Study of PR013
05 Dec 2017 07:00 Realm Therapeutics 0.30%
First Patient Dosed in Phase 2 Study of PR022
17 Nov 2017 07:00 Realm Therapeutics 0.30%
Directorate Change
12 Oct 2017 15:07 Realm Therapeutics 0.30%
Realm Therapeutics: Completion of £19.3m Placing
09 Oct 2017 11:35 Realm Therapeutics 0.30%
Result of General Meeting
22 Sep 2017 07:00 Realm Therapeutics 0.30%
Interim Results
22 Sep 2017 07:00 Realm Therapeutics 0.30%
Proposed Placing to raise £19.3 million
21 Sep 2017 18:01 Realm Therapeutics 0.30%
Proposed Placing to raise £19.3 million
21 Sep 2017 18:00 Realm Therapeutics 0.30%
Interim Results
11 Sep 2017 07:00 Realm Therapeutics 0.30%
FDA Permits PR013 to Proceed to Phase II Trial
02 Aug 2017 07:00 Realm Therapeutics 0.30%
Submission of Investigational New Drug Application
06 Jun 2017 11:05 Realm Therapeutics 0.30%
Result of AGM
11 May 2017 12:21 Realm Therapeutics 0.30%
Notice of AGM
23 Mar 2017 14:57 Realm Therapeutics 0.30%
Annual Report and Accounts Available
23 Mar 2017 07:00 Realm Therapeutics 0.30%
Final Results and Business Update
28 Feb 2017 07:00 Realm Therapeutics 0.30%
FDA permits PR022 to Proceed to Phase 2 Trial
30 Jan 2017 07:00 Realm Therapeutics 0.30%
Research Update - Submission of first IND
04 Jan 2017 07:00 Realm Therapeutics 0.30%
Grant of Options
21 Dec 2016 07:00 Realm Therapeutics 0.30%
PDMR dealing
16 Dec 2016 07:00 Realm Therapeutics 0.30%
Ivan Gergel appointed as Non-Executive Director
07 Dec 2016 07:00 Realm Therapeutics 0.30%
Change of name to Realm Therapeutics
18 Nov 2016 07:00 Realm Therapeutics 0.30%
Grant of Options
16 Nov 2016 07:00 Realm Therapeutics 0.30%
Development Programmes Update & Company Renaming
10 Oct 2016 07:00 Realm Therapeutics 0.30%
Completion of Supermarket Retail Business Disposal
07 Oct 2016 17:52 Realm Therapeutics 0.30%
Completion of Supermarket Retail Business Disposal
06 Oct 2016 11:43 Realm Therapeutics 0.30%
Result of General Meeting
23 Sep 2016 14:47 Realm Therapeutics 0.30%
Director/PDMR Dealing
22 Sep 2016 14:15 Realm Therapeutics 0.30%
Grant of Options
20 Sep 2016 07:00 Realm Therapeutics 0.30%
Half-year Report
20 Sep 2016 07:00 Realm Therapeutics 0.30%
Proposed Disposal of Supermarket Retail Business
17 Aug 2016 07:00 Realm Therapeutics 0.30%
PuriCore Receives Two U.S. Patents
16 Jun 2016 11:39 Realm Therapeutics 0.30%
Result of AGM
09 Jun 2016 07:00 Realm Therapeutics 0.30%
Completion of Pre-IND Meeting with FDA on PR022
27 May 2016 07:00 Realm Therapeutics 0.30%
Resolution reached with EPA
14 Apr 2016 07:00 Realm Therapeutics 0.30%
Appointment of Dr. Christian Peters as CMO
31 Mar 2016 07:00 Realm Therapeutics 0.30%
Notice of AGM
29 Mar 2016 15:11 Realm Therapeutics 0.30%
Director Dealing
29 Mar 2016 07:00 Realm Therapeutics 0.30%
Grant of Options
24 Mar 2016 15:22 Realm Therapeutics 0.30%
Annual Financial Report
24 Mar 2016 07:00 Realm Therapeutics 0.30%
Final Results
01 Mar 2016 07:00 Realm Therapeutics 0.30%
Appointment of Dr Simba Gill to the Board
19 Feb 2016 09:30 Realm Therapeutics 0.30%
Blocklisting Interim Review
08 Feb 2016 07:00 Realm Therapeutics 0.30%
Strategic Review and Trading Update
14 Oct 2015 17:13 Realm Therapeutics 0.30%
Director Dealing